US Stock MarketDetailed Quotes

ASLN Aslan Pharmaceuticals

Watchlist
  • 0.6000
  • -0.0999-14.27%
Close Jul 18 16:00 ET
  • 0.5900
  • -0.0100-1.67%
Post 19:50 ET
1.70MMarket Cap-38P/E (TTM)

Aslan Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aslan Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-4.00

+60.00%
Analyst Rating

Buy

Jul 3, 2024

Aslan Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: TWD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Aslan Pharmaceuticals Earnings Reports

  • Aslan Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    May 31 16:31 ET

  • Aslan Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    May 9 07:12 ET

  • Aslan Pharmaceuticals | 20-F: Registration statement / Annual report / Transition report

    Apr 12 06:31 ET

  • Aslan Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 12 06:07 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 3, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg